Related Experiment Video
Updated: Sep 8, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
A New Strategy for Efficient Retrospective Data Analyses for Designer Benzodiazepines in Large LC-HRMS Datasets.
Meiru Pan1, Brian Schou Rasmussen1, Petur Weihe Dalsgaard1
1Department of Forensic Medicine, University of Copenhagen, Copenhagen, Denmark.
This study introduces an efficient retrospective data analysis (RDA) workflow to detect new psychoactive substances (NPSs), specifically designer benzodiazepines (DBZDs), in previously analyzed forensic samples. The method significantly enhances the ability to monitor NPS abuse by rapidly screening large datasets for emerging drugs.
Area of Science:
- Forensic Chemistry
- Analytical Chemistry
- Mass Spectrometry
Background:
- The increasing prevalence of new psychoactive substances (NPSs) presents analytical challenges for forensic laboratories.
- Retrospective data analysis (RDA) offers a way to identify previously missed analytes but is often time-consuming and labor-intensive.
- Developing efficient and scalable workflows is crucial for monitoring NPS abuse.
Purpose of the Study:
- To establish an efficient and scalable retrospective data analysis (RDA) workflow for detecting designer benzodiazepines (DBZDs) in whole blood samples.
- To apply this workflow to previously analyzed driving-under-the-influence-of-drugs (DUID) cases.
- To optimize the workflow for groups of NPSs, particularly benzodiazepines.
Main Methods:
- Developed an RDA workflow utilizing ultrahigh-performance liquid chromatography-quadrupole time-of-flight-mass spectrometry (UHPLC-QTOF-MS) data.
- Used a training set of confirmed benzodiazepine hits (analyzed by UHPLC-MS/MS) to establish true/false positive criteria and set filters (retention time, count, mass error).
- Applied the validated workflow to 13,514 UHPLC-QTOF-MS data files from DUID cases (2014-2020) to screen for 47 targeted DBZDs.
Main Results:
- The RDA workflow successfully identified 16 designer and uncommon benzodiazepines (DBZDs) in the analyzed DUID cases.
- A total of 47 confirmed positive findings and 43 tentative positive findings were reported.
- The method demonstrated high efficiency with only nine false-positive hits and the capability to screen previously acquired DUID data files for emerging DBZDs in under one minute.
Conclusions:
- The developed RDA workflow is an efficient, scalable, and accurate method for identifying DBZDs in large forensic datasets.
- This technological advancement significantly improves the monitoring of NPS abuse by enabling rapid screening of historical data.
- The workflow can be easily adapted for other groups of NPSs, offering a valuable tool for forensic laboratories worldwide.
More Related Videos
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...